Risk factors for multimorbidity in adulthood: A systematic review

C Tazzeo, A Zucchelli, DL Vetrano, J Demurtas… - Ageing Research …, 2023 - Elsevier
Background Multimorbidity, the coexistence of multiple chronic diseases in an individual, is
highly prevalent and challenging for healthcare systems. However, its risk factors remain …

[HTML][HTML] Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)

MM Ali, S Parveen, V Williams, R Dons… - Journal of clinical & …, 2024 - Elsevier
Obesity and chronic kidney disease are two ongoing progressive clinical pandemics of
major public health and clinical care significance. Because of their growing prevalence …

Association of changes in waist circumference, waist-to-height ratio and weight-adjusted-waist index with multimorbidity among older Chinese adults: results from the …

ZT Chen, XM Wang, YS Zhong, WF Zhong, WQ Song… - BMC Public Health, 2024 - Springer
Background The association of changes in waist circumference (WC), waist-to-height ratio
(WHtR) and weight-adjusted-waist index (WWI) with subsequent risk of multimorbidity …

Determinants of multimorbidity in low‐and middle‐income countries: A systematic review of longitudinal studies and discovery of evidence gaps

MMC Tan, MG Barbosa, PJMR Pinho… - Obesity …, 2024 - Wiley Online Library
Multimorbidity—the coexistence of at least two chronic health conditions within the same
individual—is an important global health challenge. In high‐income countries (HICs) …

Obesity and risk of diseases associated with hallmarks of cellular ageing: a multicohort study

M Kivimäki, P Frank, J Pentti, X Xu… - The Lancet Healthy …, 2024 - thelancet.com
Background Ageing hallmarks, characterising features of cellular ageing, have a role in the
pathophysiology of many age-related diseases. We examined whether obesity is associated …

Progress in the contrary effects of glucagon-like peptide-1 and chemerin on obesity development

Q Zhang, J Ye, X Wang - Experimental Biology and Medicine, 2023 - journals.sagepub.com
Glucagon-like peptide-1 (GLP-1), secreted by intestinal L-cells, plays a pivotal role in the
modulation of β-cell insulin secretion in a glucose-dependent manner, concurrently …

Care models for individuals with chronic multimorbidity: lessons for low-and middle-income countries

A Endalamaw, A Zewdie, E Wolka, Y Assefa - BMC health services …, 2024 - Springer
Background Patients with multiple long-term conditions requires understanding the existing
care models to address their complex and multifaceted health needs. However, current …

[HTML][HTML] Drug–Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance Database

CM Dobrea, A Frum, A Butuca, C Morgovan… - …, 2024 - pmc.ncbi.nlm.nih.gov
As the most common psychiatric symptom, depression represents a subject of high interest
for the medical community. Background/Objectives: International guidelines consider …

Body mass index and multimorbidity risk: A systematic review and dose-response meta-analysis

J Shan, R Yin, S Panuthai - Archives of gerontology and geriatrics, 2024 - Elsevier
Objective To verify the dose-response relationship between body mass index (BMI) and
multimorbidity risk. Methods PubMed, CINAHL, and Embase were systematically studied …

The various associations between whole/regional fat mass and trajectory of cardiometabolic diseases: a nonlinear multistate model

X Xu, Y Guo, L Huang, BR Song, D Chen, F Weng… - …, 2025 - Wiley Online Library
Objective This study aimed to investigate the association of whole body/regional fat mass
(FM) with cardiometabolic disease (CMD) trajectory. Methods We conducted a prospective …